Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo-controlled trial

Arthritis Care and Research

Volumn 62, Issue 9, 2010, Pages 1266-1271

  Deodhar, Atul ^a   Braun, Jürgen ^b   Inman, Robert D ^c   Mack, Michael ^d   Parasuraman, Shreekant ^e   Buchanan, Jacqueline ^e   Hsu, Benjamin ^d   Gathany, Tim ^e   Van Der Heijde, Désirée ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b RHEUMAZENTRUM RUHRGEBIET   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTOCOR INC   (United States)

^e Johnson and Johnson Pharmaceutical Services   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GOLIMUMAB; PLACEBO; ANTIRHEUMATIC AGENT; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP DISORDER; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ANTAGONISTS AND INHIBITORS; COMPLICATION; DOSE RESPONSE; FATIGUE; SLEEP DISORDERS; SPONDYLITIS, ANKYLOSING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; MALE; SLEEP DISORDERS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956396153     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20233     Document Type: Article

References (19)

1. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006;54:569-78.
2. Calin A, Edmunds L, Kennedy LG. Fatigue in ankylosing spondylitis: why is it ignored? J Rheumatol 1993;20:991-5.
3. Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 2005;53:5-11. (Pubitemid 40216345)
4. Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). J Rheumatol 2008;35:1346-53.
5. Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis: progress at OMERACT 7. J Rheumatol 2005;32:2250-6. (Pubitemid 41587877)
6. Hultgren S, Broman JE, Gudbjornsson B, Hetta J, Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitis questionnaire study with gender implications. Scand J Rheumatol 2000;29:365-9.
7. Gudbjornsson B, Broman JE, Hetta J, Hallgren R. Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol 1993;32:1072-6.
8. Karapolat H, Akkoc Y, Sari I, Eyigor S, Akar S, Kirazli Y, et al. Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression. Clin Rheumatol 2008;27:695-700.
9. Carr-Hill RA, Kind P. The Nottingham health profile [letter]. Soc Sci Med 1989;28:885.
10. Gunaydin R, Goksel Karatepe A, Cesmeli N, Kaya T. Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbance. Clin Rheumatol 2009;28:1045-51.
11. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
12. Inman RD, Davis JC Jr, van der Heijde D, Diekman L, Sieper J, Kim SI, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 2008;58:3402-12.
13. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313-21.
14. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
15. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
17. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute; 1994.
18. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology [editorial]. J Rheumatol 1998;25:198-9.
19. Nasermoaddeli A, Sekine M, Kumari M, Chandola T, Marmot M, Kagamimori S. Association of sleep quality and free time leisure activities in Japanese and British civil servants. J Occup Health 2005;47:384-90. (Pubitemid 41436301)